Q/C Technologies, Inc. Stock Issued During Period, Value, Stock Dividend
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Q/C Technologies, Inc. stock issued during period, value, stock dividend for the quarter ending 2024-03-31 was $1.20M, a 659.08% increase year-over-year.
- Q/C Technologies, Inc. stock issued during period, value, stock dividend for the quarter ending 2023-09-30 was $391.55K.
- Q/C Technologies, Inc. stock issued during period, value, stock dividend for the quarter ending 2023-06-30 was $373.80K.
- Q/C Technologies, Inc. stock issued during period, value, stock dividend for the quarter ending 2023-03-31 was $158.33K.
- Q/C Technologies, Inc. stock issued during period, value, stock dividend for fiscal 2023 was $2.79M.
| Period end | Stock Issued During Period, Value, Stock Dividend 3 month | Stock Issued During Period, Value, Stock Dividend 12 month |
|---|---|---|
| 2024-03-31 | $1.20M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $2.79M 10-K · filed 2024-04-01 | |
| 2023-09-30 | $391.55K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $373.80K 10-Q · filed 2023-11-14 | |
| 2023-03-31 | $158.33K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |